Testing effectiveness (Phase 2)Ended earlyNCT01823835
What this trial is testing
GDC-0810 Single Agent or in Combination With Palbociclib and/or a Luteinizing Hormone-Releasing Hormone (LHRH) Agonist in Women With Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer
Who this might be right for
Breast Cancer
Genentech, Inc. 152